Redmile Group’s Evolent Health EVH Stock Holding History

Redmile Group’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-679,172	Closed	-$22.3M	–	71
2024 Q1	$22.3M	Sell	679,172 -156,365	-19%	-$4.99M	0.82%	39
2023 Q4	$27.6M	Buy	835,537 +370,255	+80%	+$10.5M	0.99%	30
2023 Q3	$12.7M	Buy	465,282 +251,850	+118%	+$7M	0.6%	39
2023 Q2	$6.47M	Buy	+213,432	New	+$6.9M	0.25%	56

Other funds holding EVH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Redmile Group's EVH Position: Q2 2024 in Review

Redmile Group sold out of Evolent Health (EVH) in Q2 2024, closing a stake of 679,172 shares — an estimated $22.3M sold.

Redmile Group first reported a position in EVH in Q2 2023 and held it in 4 quarters. The position peaked at $27.6M in Q4 2023. 243 funds tracked by Wall St. Rank hold EVH as of Q2 2024.

Redmile Group reported no remaining Evolent Health position as of Q2 2024 after selling out during the quarter.
Redmile Group sold 679,172 Evolent Health shares in Q2 2024, an estimated $22.3M.
Redmile Group first reported a position in Evolent Health in Q2 2023 and held it in 4 quarters.
Redmile Group's Evolent Health position peaked at $27.6M in Q4 2023.
243 funds tracked by Wall St. Rank held Evolent Health as of Q2 2024.

Based on Redmile Group's 13F filing for Q2 2024, filed 14 Aug 2024.